Cat. #161085
Lupeol
Cat. #: 161085
Sub-type: Inhibitor
Availability: 3-4 weeks
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: UJInvnt (Pty) Ltd
Primary Citation: Palanimuthu et al. 2012 Oct. Pathol Oncol Res. 18(4):1029-37. PMID: 22806881
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Tool name: Lupeol
- Research fields: Cancer
- Molecular formula: C30H50O
- Tool sub type: Inhibitor
- Primary target: Multiple targets; IL-1 receptor-associated kinase-mediated toll-like receptor 4 (IRAK-TLR4), Bcl-2 family, nuclear factor kappa B (NF-kB), phosphatidylinositol-3-kinase (PI3-K)/Akt and Wnt/?-catenin
- Description: Multi target agent to exert diverse pharmalogical potency with many potential target proteins
- Purpose: Inhibitor
- Iupac: (1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol
- Molecular weight: 426.7
Handling
- Storage conditions: Store at -20° C
- Shipping conditions: Dry Ice
Target Details
- Primary target: Multiple targets; IL-1 receptor-associated kinase-mediated toll-like receptor 4 (IRAK-TLR4), Bcl-2 family, nuclear factor kappa B (NF-kB), phosphatidylinositol-3-kinase (PI3-K)/Akt and Wnt/?-catenin
References
- Palanimuthu et al. 2012 Oct. Pathol Oncol Res. 18(4):1029-37. PMID: 22806881
